Brisbane Clinical Trials
The Comfort Study
The purpose of this study is to investigate the safety and efficacy of a new medication that is designed to relieve asthma symptoms in patients who suffer from severe uncontrolled asthma.
6 nights
13 visits
SHR-1905 can inhibit one of the key cell types involved in the inflammatory process which causes asthma. So, SHR-1905 may improve both asthma control and prevent asthma attack. This part of the study is designed to investigate how the study drug is metabolised in healthy participants who do not suffer from asthma.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!
Eligibility
Biological Sex Healthy males or females
Age 18-55 years old, inclusive
BMI 18 -30 kg/m²
Medication not taking any medication (contraception allowed)
Medical History Nothing significant
Smoking History Non-smokers or smoking less than 5 cigarettes per day